<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/57150975-2FFC-442F-A99E-ABD25A46F8D2"><gtr:id>57150975-2FFC-442F-A99E-ABD25A46F8D2</gtr:id><gtr:name>Pasteur Institute, Paris</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/80392F0C-23A4-449D-BC8D-4D77C0F53303"><gtr:id>80392F0C-23A4-449D-BC8D-4D77C0F53303</gtr:id><gtr:name>Mahidol University</gtr:name><gtr:address><gtr:line1>Mahidol University</gtr:line1><gtr:line2>Office of the President  Mahidol Univers</gtr:line2><gtr:line3>25/25 Moo 3, Phuttamonthon 4 Road</gtr:line3><gtr:postCode>73170</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>Dept of Medicine</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/57150975-2FFC-442F-A99E-ABD25A46F8D2"><gtr:id>57150975-2FFC-442F-A99E-ABD25A46F8D2</gtr:id><gtr:name>Pasteur Institute, Paris</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/80392F0C-23A4-449D-BC8D-4D77C0F53303"><gtr:id>80392F0C-23A4-449D-BC8D-4D77C0F53303</gtr:id><gtr:name>Mahidol University</gtr:name><gtr:address><gtr:line1>Mahidol University</gtr:line1><gtr:line2>Office of the President  Mahidol Univers</gtr:line2><gtr:line3>25/25 Moo 3, Phuttamonthon 4 Road</gtr:line3><gtr:postCode>73170</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/F0DDF24E-7698-449D-BF5C-2B2BB0DD500A"><gtr:id>F0DDF24E-7698-449D-BF5C-2B2BB0DD500A</gtr:id><gtr:firstName>Gavin</gtr:firstName><gtr:otherNames>Robert</gtr:otherNames><gtr:surname>Screaton</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/898FEB26-C34F-4C00-BD46-D8444A99EC6F"><gtr:id>898FEB26-C34F-4C00-BD46-D8444A99EC6F</gtr:id><gtr:firstName>Juthathip</gtr:firstName><gtr:surname>Mongkolsapaya</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0600000"><gtr:id>6E54CEA3-40AA-4653-BA0F-011554F988BD</gtr:id><gtr:title>A study of the human antibody response in Dengue haemorrhagic fever</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0600000</gtr:grantReference><gtr:abstractText>Dengue virus infects humans following the bite from an infected mosquito. The disease occurs in tropical and subtropical countries where it is becoming a rapidly increasing threat to health, currently affecting around 50 million people per year. In its more severe forms Dengue can cause haemorrhagic fever which is life threatening. There is a great need for an effective Dengue vaccine. These studies to understand the immune response to Dengue virus are designed to aid in this effort.</gtr:abstractText><gtr:technicalSummary>Dengue virus infection is a growing threat to public health in a number of tropical and subtropical countries. Dengue co-circulates as four distinct serotypes and immunity to one serotype does not confer immunity to the others. Indeed, good epidemiological evidence suggests that the most severe forms of the disease, Dengue haemorrhagic fever, occurs when individuals become secondarily infected with a Dengue virus of different serotype to the primarily infecting virus. The potentiation of disease on secondary infection is a major challenge to vaccine design as a poor vaccine which did not achieve cross-serotype protection may end up actually mimicking natural infection and enhancing disease. The phenomenon of antibody dependent enhancement has been demonstrated by Halstead whereby poorly neutralising antibodies may opsonise the virus and lead to its uptake by Fc receptor bearing cells and thus actually enhance infection and virus replication in macrophages, a principle host cell type in Dengue infection.

Much work has been done characterising antibody responses to Dengue but almost all of this has involved the study of monoclonal antibodies generated in the mouse. Recently, an exciting new technique has been described which allows the generation of human monoclonal antibodies from infected individuals. We aim to clone a series of such mAb and to then carry out a detailed virological and structural analysis of their reactivity. These studies will make an important contribution to our knowledge of Dengue immunity and will also aid to efforts to design and monitor effective vaccines.</gtr:technicalSummary><gtr:fund><gtr:end>2010-08-27</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-08-28</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>335239</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Mahidol University</gtr:collaboratingOrganisation><gtr:country>Thailand, Kingdom of</gtr:country><gtr:department>Siriraj Hospital</gtr:department><gtr:description>Dengue clinical centres</gtr:description><gtr:id>53F31304-EEC4-4386-BB6D-D6BC601BDD2C</gtr:id><gtr:impact>publications</gtr:impact><gtr:partnerContribution>Sample collection and processing</gtr:partnerContribution><gtr:piContribution>We get our samples from Thailand to measure biomarkers</gtr:piContribution><gtr:sector>Hospitals</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pasteur Institute, Paris</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Felix Rey</gtr:description><gtr:id>406A3BA9-429E-4C77-8A92-57576FB0B71D</gtr:id><gtr:impact>None yet</gtr:impact><gtr:partnerContribution>Felix Rey at Pasteur solves the structures of antibodies bound to dengue antigens</gtr:partnerContribution><gtr:piContribution>We make monoclonal antibodies</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Division of Infectious Diseases Symposium</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B22AC14F-5044-4EC6-BB9E-5869AFD37FD2</gtr:id><gtr:impact>Piecing together the Puzzle of Severe Malaria
Keynote presentation: Prof David Salisbury, Head of Immunisation, Public Health England
Latest trends in Infectious diseases

Better understanding of latest trends in Infectious diseases</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>International Congress on Medical Virology 2014</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>FFF9CAF3-DE54-4407-A32E-8CC3BDA63FD4</gtr:id><gtr:impact>I lectured on protective and pathogenic immunity in dengue virus infection and it sparked questions.

N.A.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.icmv2014.com/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>British Society for Immunology Congress 2013</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>595A0401-8A9D-4CF1-BA51-C2CDA2D5E79F</gtr:id><gtr:impact>British Society for Immunology Congress 2013 in Liverpool from 2nd to 5th December. Title was &amp;quot;Protective and pathogenic immunity in dengue virus infection&amp;quot;.

Generated interest.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:url>http://www.bsicongress.com</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Association of Physicians annual meeting</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>18690FDE-8C78-451A-8599-DA16AC40B9EE</gtr:id><gtr:impact>Latest trends in medicine

knowledge of latest trends in medicine</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>CIDRI Meeting</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>CDFCC267-6E06-43D6-8E20-89BC0E2DEFCD</gtr:id><gtr:impact>Meeting with Prof Bongani M. Mayosi, Head, DoM , UCT
Meeting with Prof Willem (Wim) de Villiers, Dean of Health Sciences, UCT
Meeting with Valerie Mizrahi, Director of IDM (Inst. of ID &amp;amp; Molecular Med)
 Talks sparked questions and there were extensive discussions
better understanding of Research Entry awards available to scientists

Improvement of clinical and laboratory facilities for patients and staff.
Further work on co-ordinate research meetings within Africa and facilitate international networking for the benefit of all researchers especially the awardees has been initiated.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.cidri.uct.ac.za/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>News</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>55576EBD-B753-4943-BE35-F66ABBA946DA</gtr:id><gtr:impact>The news was reported on BBC News, Wellcome Trust website, Imperial College website and Science daily.

The finding alerts awareness of the dengue problem.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>700000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Biomarkers grant</gtr:description><gtr:end>2012-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>79D82691-4C1A-419C-8ED7-F9232CEEB303</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>494207</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>DENFREE - Dengue research framework for resisting epidemics in Europe</gtr:description><gtr:end>2016-06-02</gtr:end><gtr:fundingOrg>Community Research and Development Information Service (CORDIS)</gtr:fundingOrg><gtr:id>1053D55D-FF26-4C3D-88FD-76714F652929</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2012-07-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Wellcome Centre for Clinical Tropical Medicine/Global Health Research annual meeting 2013</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>B7573F61-731F-4B29-973C-0F8ABB8DE9B2</gtr:id><gtr:impact>Understanding Dengue pathogenesis and prospects for vaccine</gtr:impact><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>HVBD DART 2013 First International Symposium on Human Vector-Borne Diseases Satellite Symposium</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>E885F6F5-912C-40A3-BFBD-63BEB9CD033E</gtr:id><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>World Innovation Summit for Health</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>D12C9112-284C-4EFA-97CC-12EE7CBBF31D</gtr:id><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Antigen-specific B cell clones were generated from B cells taken from dengue-infected individuals. B cells were immortalized by EBV and screened for B cells which express anti-dengue specific antibodies. We have a panel of B cell clones recognize structural and nonstructural dengue proteins.</gtr:description><gtr:id>95EDA633-ADCE-4793-9D85-6858896C6ED7</gtr:id><gtr:impact>The materials can be use for understanding antibody responses against dengue infection. The monoclonal antibodies are ideal for studying mechanism of antibody-virus interaction at a molecular level and their effects on the pathogenesis and protection.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>antigen-specific B cell clones and human anti-dengue monoclonal antibodies</gtr:title><gtr:type>Antibody</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/207F0540-0FC3-4D9F-A8CD-3891CF3354FD"><gtr:id>207F0540-0FC3-4D9F-A8CD-3891CF3354FD</gtr:id><gtr:title>Structural basis of potent Zika-dengue virus antibody cross-neutralization.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6be8fbe643ad7e1ee8e12b8c197087fb"><gtr:id>6be8fbe643ad7e1ee8e12b8c197087fb</gtr:id><gtr:otherNames>Barba-Spaeth G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EFC8AE9B-3021-4218-AF54-52013FBDD50D"><gtr:id>EFC8AE9B-3021-4218-AF54-52013FBDD50D</gtr:id><gtr:title>Antibodies and tuberculosis.</gtr:title><gtr:parentPublicationTitle>Tuberculosis (Edinburgh, Scotland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d8f652ecc13085fce6584f220c0089a9"><gtr:id>d8f652ecc13085fce6584f220c0089a9</gtr:id><gtr:otherNames>Jacobs AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1472-9792</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E54D0F0D-3F78-4382-A2C1-53E64D71F0CA"><gtr:id>E54D0F0D-3F78-4382-A2C1-53E64D71F0CA</gtr:id><gtr:title>A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d1383435e43602a50e492d78c4647d72"><gtr:id>d1383435e43602a50e492d78c4647d72</gtr:id><gtr:otherNames>Dejnirattisai W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B8E6DBD3-7281-4C4B-90B6-A65DFBC1EF31"><gtr:id>B8E6DBD3-7281-4C4B-90B6-A65DFBC1EF31</gtr:id><gtr:title>Association of Microvascular Function and Endothelial Biomarkers With Clinical Outcome in Dengue: An Observational Study.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c1ac033a4df3945c2f4707dddd3643e8"><gtr:id>c1ac033a4df3945c2f4707dddd3643e8</gtr:id><gtr:otherNames>Yacoub S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/ABD25EB4-795D-492F-B09B-82FEFF7C0299"><gtr:id>ABD25EB4-795D-492F-B09B-82FEFF7C0299</gtr:id><gtr:title>Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d1383435e43602a50e492d78c4647d72"><gtr:id>d1383435e43602a50e492d78c4647d72</gtr:id><gtr:otherNames>Dejnirattisai W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1806B652-447F-4819-9479-B309F2DA8D1C"><gtr:id>1806B652-447F-4819-9479-B309F2DA8D1C</gtr:id><gtr:title>Recognition determinants of broadly neutralizing human antibodies against dengue viruses.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6c031b5eaaf37d25bcbf7f60664e712c"><gtr:id>6c031b5eaaf37d25bcbf7f60664e712c</gtr:id><gtr:otherNames>Rouvinski A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D030C61F-CCAC-4BC0-9DBD-92B4A2049AF3"><gtr:id>D030C61F-CCAC-4BC0-9DBD-92B4A2049AF3</gtr:id><gtr:title>Microvascular and endothelial function for risk prediction in dengue: an observational study.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c1ac033a4df3945c2f4707dddd3643e8"><gtr:id>c1ac033a4df3945c2f4707dddd3643e8</gtr:id><gtr:otherNames>Yacoub S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/95EF8B00-336C-4D66-BA59-808D485F35CE"><gtr:id>95EF8B00-336C-4D66-BA59-808D485F35CE</gtr:id><gtr:title>New insights into the immunopathology and control of dengue virus infection.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9db9055b9d654d1ad5a92d6548d2a1bb"><gtr:id>9db9055b9d654d1ad5a92d6548d2a1bb</gtr:id><gtr:otherNames>Screaton G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1474-1733</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D7FC2DCD-8553-479D-95CC-52F384275480"><gtr:id>D7FC2DCD-8553-479D-95CC-52F384275480</gtr:id><gtr:title>MAIT cells are activated during human viral infections.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fd9c5d3ad67e5b8adc8f4409ebdea785"><gtr:id>fd9c5d3ad67e5b8adc8f4409ebdea785</gtr:id><gtr:otherNames>van Wilgenburg B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CC3F46E8-1217-4C2A-9EFA-19188A7E7A77"><gtr:id>CC3F46E8-1217-4C2A-9EFA-19188A7E7A77</gtr:id><gtr:title>Cross-reacting antibodies enhance dengue virus infection in humans.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d1383435e43602a50e492d78c4647d72"><gtr:id>d1383435e43602a50e492d78c4647d72</gtr:id><gtr:otherNames>Dejnirattisai W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/91D89209-69BA-4CE8-85BC-FD872545CE2A"><gtr:id>91D89209-69BA-4CE8-85BC-FD872545CE2A</gtr:id><gtr:title>Remarkably low affinity of CD4/peptide-major histocompatibility complex class II protein interactions.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f35343efd6a5a8ddc873888ac57c309d"><gtr:id>f35343efd6a5a8ddc873888ac57c309d</gtr:id><gtr:otherNames>J?nsson P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/081A6EF8-9D4B-455B-A866-2F8E05E6F63D"><gtr:id>081A6EF8-9D4B-455B-A866-2F8E05E6F63D</gtr:id><gtr:title>An in-depth analysis of original antigenic sin in dengue virus infection.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/10ed0f78d99370f902a6926e13983a6b"><gtr:id>10ed0f78d99370f902a6926e13983a6b</gtr:id><gtr:otherNames>Midgley CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BD724964-9A56-4B1C-BABF-4988DCD87263"><gtr:id>BD724964-9A56-4B1C-BABF-4988DCD87263</gtr:id><gtr:title>Recent advances in understanding dengue.</gtr:title><gtr:parentPublicationTitle>F1000Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c1ac033a4df3945c2f4707dddd3643e8"><gtr:id>c1ac033a4df3945c2f4707dddd3643e8</gtr:id><gtr:otherNames>Yacoub S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2046-1402</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0B38BC4F-DD8C-47E9-AFBC-5F43AB43B345"><gtr:id>0B38BC4F-DD8C-47E9-AFBC-5F43AB43B345</gtr:id><gtr:title>Synovial IL-21/TNF-producing CD4(+) T cells induce joint destruction in rheumatoid arthritis by inducing matrix metalloproteinase production by fibroblast-like synoviocytes.</gtr:title><gtr:parentPublicationTitle>Journal of leukocyte biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d93e20bb653711bec5e0ee4ed73e3839"><gtr:id>d93e20bb653711bec5e0ee4ed73e3839</gtr:id><gtr:otherNames>Lebre MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0741-5400</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FCC07F33-B4E1-424A-BB93-F6A7AA1825C8"><gtr:id>FCC07F33-B4E1-424A-BB93-F6A7AA1825C8</gtr:id><gtr:title>Lectin switching during dengue virus infection.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d1383435e43602a50e492d78c4647d72"><gtr:id>d1383435e43602a50e492d78c4647d72</gtr:id><gtr:otherNames>Dejnirattisai W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0600000</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>